liposomal glutathione gsh Oral supplementation with elevates body stores of glutathione and markers of immune function Liposomal Glutathione 500mg 120 Count

Advances in chronic kidney disease

BPC-157 is supplied strictly as a research compound for in-vitro and laboratory use

Yet, despite some compelling results with specific agents in pre-clinical animal models of TBI and Phase I/II trials in patients, there are currently no FDA approved drugs for TBI which have shown significant therapeutic efficacy in large, randomized Phase III clinical trials

In comparison, the LD50 value for aspirin is 200 mg/kg when administered orally

Indoxyl sulfate affects glial function increasing oxidative stress and Neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia